An Indian court has cleared the way for low-cost alternatives to Roche’s drug Evrysdi for spinal muscular atrophy. What’s behind the decision and what could it mean for rare disease patients everywhere? On October 9 the Delhi High Court refused to issue Roche an injunction to prevent generic manufacturers from making and selling a low-cost version of one of the company’s top selling drugs. The drug risdiplam, sold by the Swiss pharma giant as Evrysdi, was first approved in the US in 2020 for the treatment of spinal muscular atrophy – a genetic disease that leads to muscle loss and wasting. Babies with the most serious form of the disease often don’t live past their second birthday. What does the Delhi court’s ruling mean for patients in India and beyond? Alpana Sharma, the founder of the patient advocacy group Cure SMA Foundation India, told Swissinfo via email that the court’s “move has the potential to significantly improve access to affordable treatment options for SMA patients ...
Full story here
Are you the author?
Previous post
See more for
Next post
Tags: Featured,newsletter
Home › 3) Swiss Markets and News › 3.) Swissinfo Business and Economy › Patent battle in India tests Roche’s grip on rare disease market
Previous post
Next post
Patent battle in India tests Roche’s grip on rare disease market
Published on October 16, 2025
Permanent link to this article: https://snbchf.com/2025/10/patent-india-tests-roche-disease-market/
Receive a Daily Mail from this Blog
Live Currency Cross Rates
On Swiss National Bank
-
SNB Sight Deposits: increased by 1.7 billion francs compared to the previous week
3 days ago -
2025-07-31 – Interim results of the Swiss National Bank as at 30 June 2025
2025-07-31 -
SNB Brings Back Zero Percent Interest Rates
2025-06-26 -
Hold-up sur l’eau potable (2/2) : la supercherie de « l’hydrogène vert ». Par Vincent Held
2025-06-24 -
2025-06-25 – Quarterly Bulletin 2/2025
2025-06-25
Main SNB Background Info
-
SNB Sight Deposits: increased by 1.7 billion francs compared to the previous week
3 days ago -
The Secret History Of The Banking Crisis
2017-08-14 -
SNB Balance Sheet Now Over 100 percent GDP
2016-08-29 -
The relationship between CHF and gold
2016-07-23 -
CHF Price Movements: Correlations between CHF and the German Economy
2016-07-22
Featured and recent
-
Bitcoin, Dogecoin, Ethereum & Co. am Samstagnachmittag
-
Bitcoin-Bullrun 2026: Krypto-Börse prognostiziert Kursziel von 170’000 Dollar -
12-20-25 Why Balanced Portfolios Are Making a Comeback -
Meine Gedanken zu Weihnachten für Sie! -
Risikomanagement beim Trading: Dein Schlüssel zum Erfolg -
Warum Dein Depot keine Angst vor Trump haben muss -
12-19-25 What Great Financial Planning Looks Like -
Are Gold’s Gains Signaling a Dramatic Paradigm Shift? -
12-29-25 Fed Liquidity, Housing Myths & Market Risk -
Inflation and the Intergenerational Housing Rivalry
More from this category
- Bitcoin, Dogecoin, Ethereum & Co. am Samstagnachmittag
20 Dec 2025
Bitcoin-Bullrun 2026: Krypto-Börse prognostiziert Kursziel von 170’000 Dollar20 Dec 2025
- Inflation and the Intergenerational Housing Rivalry
19 Dec 2025
- Home Prices and Sales Fall. Can Sellers Count on Lower Interest Rates?
19 Dec 2025
- Inflation as a moral hazard
19 Dec 2025
Nestlé allowed to continue French Perrier operations19 Dec 2025
- Nagel on Reason
19 Dec 2025
- Why We Hate Thomas Hobbes
19 Dec 2025
Truth or tale: Would inheritance taxes trigger a mass exodus of millionaires from Switzerland? 19 Dec 2025
BLue Owl Roils The AI Narrative19 Dec 2025
What Inflation Alarmists Missed In Their Warnings19 Dec 2025
Reduced US tariffs ‘remain a burden’ for Swiss economy19 Dec 2025
Switzerland considers AI data ‘theft’ defence19 Dec 2025
- Protecting a Societal Cancer with a Web of Lies
19 Dec 2025
Record number of guests in 2025: Swiss tourism boss19 Dec 2025
- Party Over Principle: A Lesson from the Bloody Shirt Era
19 Dec 2025
- Inflation and the Intergenerational Housing Rivalry
18 Dec 2025
UBS plans January job cuts: media report18 Dec 2025
- QJAE: Ulysses S. Grant and the Panic of 1873
18 Dec 2025
- November’s Weak Jobs Report Pushes the Fed Toward More Monetary Stimulus
18 Dec 2025











